benzbromarone has been researched along with Protein Aggregation, Pathological in 1 studies
Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.
Protein Aggregation, Pathological: A biochemical phenomenon in which misfolded proteins aggregate either intra- or extracellularly. Triggered by factors such as MUTATION; POST-TRANSLATIONAL MODIFICATIONS, and environmental stress, it is generally associated with ALZHEIMER DISEASE; PARKINSON DISEASE; HUNTINGTON DISEASE; and TYPE 2 DIABETES MELLITUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| López, LC | 1 |
| Varea, O | 1 |
| Navarro, S | 1 |
| Carrodeguas, JA | 1 |
| Sanchez de Groot, N | 1 |
| Ventura, S | 1 |
| Sancho, J | 1 |
1 other study available for benzbromarone and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Benzbromarone, Quercetin, and Folic Acid Inhibit Amylin Aggregation.
Topics: Amyloid; Animals; Benzbromarone; Folic Acid; HeLa Cells; Humans; Islet Amyloid Polypeptide; Protein | 2016 |